A_DT
novel_JJ
function_NN
of_IN
Stat1_NN
and_CC
Stat3_NN
proteins_NNS
in_IN
erythropoietin-induced_JJ
erythroid_JJ
differentiation_NN
of_IN
a_DT
human_JJ
leukemia_NN
cell_NN
line_NN
._.

We_PRP
recently_RB
determined_VBD
that_IN
erythropoietin_NN
-LRB-_-LRB-
EPO_NN
-RRB-_-RRB-
activates_VBZ
3_CD
members_NNS
of_IN
the_DT
signal_NN
transducer_NN
and_CC
activator_NN
of_IN
transcription_NN
-LRB-_-LRB-
STAT_NN
-RRB-_-RRB-
family_NN
,_,
Stat1alpha_NN
,_,
Stat3_NN
,_,
and_CC
Stat5_NN
,_,
in_IN
the_DT
human_JJ
EPO-dependent_JJ
cell_NN
lines_NNS
,_,
UT-7_NN
and_CC
UT-7_NN
\/_:
EPO_NN
-LRB-_-LRB-
Kirito_NNP
et_FW
al_FW
,_,
J_NNP
Biol_NNP
Chem_NNP
272_CD
:_:
16507_CD
,_,
1997_CD
-RRB-_-RRB-
._.

In_IN
addition_NN
,_,
we_PRP
have_VBP
shown_VBN
that_IN
Stat1alpha_NN
,_,
but_CC
not_RB
Stat3_NN
,_,
is_VBZ
involved_VBN
in_IN
EPO-induced_JJ
cellular_JJ
proliferation_NN
._.

In_IN
this_DT
study_NN
,_,
we_PRP
examined_VBD
the_DT
roles_NNS
of_IN
Stat1alpha_NN
and_CC
Stat3_NN
in_IN
EPO-induced_JJ
erythroid_JJ
differentiation_NN
._.

UT-7_NN
\/_:
GM_NN
was_VBD
used_VBN
as_IN
a_DT
model_NN
system_NN
,_,
because_IN
this_DT
cell_NN
line_NN
can_MD
differentiate_VB
into_IN
erythroid-lineage_JJ
cells_NNS
with_IN
EPO_NN
treatment_NN
-LRB-_-LRB-
Komatsu_NNP
et_FW
al_FW
,_,
Blood_NNP
89_CD
:_:
4021_CD
,_,
1997_CD
-RRB-_-RRB-
._.

We_PRP
found_VBD
that_IN
EPO_NN
did_VBD
not_RB
activate_VB
Stat1alpha_NN
or_CC
Stat3_NN
in_IN
UT-7_NN
\/_:
GM_NN
cells_NNS
._.

Transfection_NN
experiments_NNS
showed_VBD
that_IN
both_CC
Stat1alpha_NN
and_CC
Stat3_NN
inhibited_VBD
the_DT
induction_NN
by_IN
EPO_NN
of_IN
gamma-globin_NN
and_CC
erythroid-specific_JJ
5-aminolevulinate_JJ
synthetase_NN
transcripts_NNS
,_,
resulting_VBG
in_IN
a_DT
reduction_NN
of_IN
the_DT
percentage_NN
of_IN
hemoglobin-positive_JJ
cells_NNS
._.

Dominant_JJ
negative_JJ
forms_NNS
of_IN
Stat1alpha_NN
or_CC
Stat3_NN
promoted_VBD
the_DT
EPO-induced_JJ
erythroid_JJ
differentiation_NN
of_IN
UT-7_NN
\/_:
GM_NN
cells_NNS
,_,
even_RB
in_IN
the_DT
presence_NN
of_IN
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
,_,
although_IN
this_DT
cytokine_NN
never_RB
induced_VBD
erythroid_JJ
differentiation_NN
of_IN
the_DT
parent_JJ
UT-7_NN
\/_:
GM_NN
cells_NNS
with_IN
or_CC
without_IN
EPO_NN
._.

A_DT
cell_NN
cycle_NN
analysis_NN
showed_VBD
that_IN
the_DT
constitutive_JJ
activation_NN
of_IN
Stat1alpha_NN
,_,
but_CC
not_RB
Stat3_NN
,_,
shortened_VBD
the_DT
period_NN
of_IN
G0\/G1_NN
prolongation_NN
caused_VBN
by_IN
EPO_NN
stimulation_NN
._.

Taken_VBN
together_RB
,_,
our_PRP$
data_NNS
suggest_VBP
that_IN
Stat1alpha_NN
and_CC
Stat3_NN
act_VBP
as_IN
negative_JJ
regulators_NNS
in_IN
EPO-induced_JJ
erythroid_JJ
differentiation_NN
._.

Specifically_RB
,_,
Stat1alpha_NN
may_MD
activate_VB
a_DT
cell_NN
cycle-associated_JJ
gene_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
,_,
leading_VBG
to_TO
the_DT
entry_NN
of_IN
cells_NNS
into_IN
the_DT
cell_NN
cycle_NN
._.

